Ausgabe 2/2016
Inhalt (11 Artikel)
Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
- Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Lauren Caldemeyer, Michael Dugan, John Edwards, Luke Akard
Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia
- Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Kathryn E. Flynn, Ehab Atallah
Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase
- Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Sudipto Mukherjee, Matt Kalaycio
New Methodologies in the Molecular Monitoring of CML
- Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Cecilia C. S. Yeung, Daniel Egan, Jerald Radich
Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics
- Multiple Myeloma (P Kapoor, Section Editor)
Srinath Sundararajan, Abhijeet Kumar, Neha Korde, Amit Agarwal
Diagnostic Advances in Multiple Myeloma
- Multiple Myeloma (P Kapoor, Section Editor)
Kevin Barley, Ajai Chari
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
- Open Access
- Multiple Myeloma (P Kapoor, Section Editor)
Taiga Nishihori, Jinming Song, Kenneth H. Shain
Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents
- Multiple Myeloma (P Kapoor, Section Editor)
Nitya Nathwani, Jeremy T. Larsen, Prashant Kapoor
Risk Stratification in Multiple Myeloma
- Multiple Myeloma (P Kapoor, Section Editor)
Melissa Gaik-Ming Ooi, Sanjay de Mel, Wee Joo Chng
Practical Approaches to the Management of Dual Refractory Multiple Myeloma
- Multiple Myeloma (P Kapoor, Section Editor)
Hans C. Lee, Tomer M. Mark, Jatin J. Shah
Signaling Pathways and Emerging Therapies in Multiple Myeloma
- Multiple Myeloma (P Kapoor, Section Editor)
Vijay Ramakrishnan, Anita D’Souza